Liver Transplantation

Article	Citations
Issue Information ‐ Author Checklist	71
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	60
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	51
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	48
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	47
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	45
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	44
Introducing the Certificate of Added Qualification (CAQ) Corner	43
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	43
Issue Information	41
Three problems, two viruses, and one man with a vision and voice: Larry Kramer, medical activist	41
Issue Information	41
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	41
Machine learning improves post-transplantation HCC recurrence prediction	36
Robotic liver transplantation: University of Modena experience	34
Acute liver failure: Do we have a consensus regarding management?	34
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	32
Making the best use of testing for blood phosphatidylethanol	31
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	30
Comparative analysis of early post-transplant infections after DCD with hypothermic oxygenated liver perfusion and DBD liver transplantation: A retrospective cohort study	30
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	29
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	29
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	27
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	26
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	26

Semaglutide is effective in achieving weight loss in liver transplant recipients	26
Incidence and risk factors for chronic rejection in pediatric liver transplantation	25
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	25
CAQ Corner: Deceased donor selection and management	24
Postoperative complications after liver transplantation: Are we making progress?	23
Impact of acuity circles policy on ABO blood type–related waitlist outcomes in liver transplantation	23
A pilot randomized controlled trial of a transportation assistance program in liver transplant (TAP-LT) candidates	22
Safety and feasibility of duct-to-duct biliary anastomosis in pediatric liver transplantation: A single-center retrospective study	22
PRO: All patients should receive a palliative care consult during LT evaluation	21
Issue Information ‐ Author Checklist	21
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	21
Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury–Exacerbation or mitigation?	21
Geographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion	21
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	20
Bariatric surgery post-liver transplantation: A Belgian nationwide study	20
Reply: Is viscoelastic testing missing ADAMTS13 depletion during liver transplantation?	20
From embedded interprofessional clinics to expanded alcohol-associated liver disease programs	20
Reply: Interpreting outcomes in early Liver Transplantation	20
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	19
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	19
The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change	19
Erratum	19
Issue Information ‐ Author Checklist	18
When worlds collide	18
Issue Information	18
Candidates for liver transplant evaluated at satellite clinics at a large academic transplant center are less likely to be waitlisted	17
Policy Corner: HCC exception update	17
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	16
Correlation or causation? Addressing the gap between oral dysbiosis and liver transplant outcomes	16
Twelve is the new fifteen: The evolving MELD paradigm	16
PRO: Is the management of ACLF better in a liver-dedicated ICU?	16
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	16
Letter to the Editor: ChatGPT and unknown clinical questions about liver transplantation	16
Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation	16
Operational tolerance is not always permanent	16
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes	15
Assessing hepatic arterial injuries in the setting of normothermic machine perfusion in liver transplantation: A noninvasive approach	15
Liver transplantation for pediatric liver malignancies	15
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	15
Clinical diagnosis of sarcopenia: Is it finally ready for prime time?	15
Letter to the Editor: A pioneer living donor liver transplantation with transgender man donor—breaking down the barriers to organ donation in Latin America	15
Benchmarking the real-world transplant benefit in unresectable colorectal liver metastases: A preliminary external validity assessment of the TransMet trial	15
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	15
Long‐term quality of life of living liver donors: A Japanese nationwide survey	14
Standardized upfront Glissonean approach and liver hanging maneuver reduces bile leakage from the hepatic hilum in living donors	14
PRO AI: AI-augmented allocation is in our future—We should invest the necessary resources today	14
From gut to graft: Can microbiota shape pediatric liver transplant outcomes?	14
A survey of national practice patterns of HCC surveillance for patients with Fontan-associated liver disease: A call to action	14
In memoriam: Ruud A.F. Krom, MD, PhD (1941–2024)	13
Priority for kidney after liver transplantation: A safety net for all?	13

Looking for literal improvement in liver transplant outcomes	13
Issue Information	13
Mapping out a Medication Adherence Promotion System (MAPS): Can it reduce graft rejection in pediatric liver transplantation?	13
Outcomes using steatotic liver grafts: Will machines score the final goal?	13
A new tool to predict future liver allograft dysfunction?	13
Navigating the road to liver transplantation equity	12
Cannabis and liver transplant: We need to chill, man	12
Issue Information	12
Reply: ChatGPT and unknown clinical questions about liver transplantation	12
Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle	12
Letter to the Editor: Does therapeutic plasma exchange really have a role in the treatment of hepatocellular carcinoma?	12
CAQ Corner: Liver transplantation for rare hepatobiliary malignancies	12
Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study	12
Reply: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	12
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction–associated steatotic liver disease	11
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients	11
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in three different European countries	11
Postoperative heartbreak: Takotsubo cardiomyopathy following liver transplantation	11
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	11
Erratum: The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone	11
Reply: Does the utilization of machine perfusion require a boundary for livers donated after circulatory death?	11
Metabolic issues in patients with metabolic dysfunction–associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review	11
Long-term considerations following living liver donation—Guidelines from the 2025 ILTS-iLDLT consensus conference on living liver donor safety	11
Decompensated cirrhosis but low MELD—Should we wait or refer for liver transplantation?	11
Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era	11
Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease	11
Anatomical classification and clinical outcomes of biliary strictures in living donor liver transplantation using right liver grafts	10
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	10
Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients	10
Bacterascites confers poor patient prognosis beyond MELD prediction	10
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis	10
Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room	10
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt	10
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials	10
Initial outcome of external biliary drainage in living donor liver transplantation with pure laparoscopic donor hepatectomy	10
Do not underestimate the impact of hepatic hydrothorax on survival before and after liver transplant	10
Reply: Methodological considerations for predicting HCC recurrence after liver transplantation	10
Factors associated with receiving a liver transplant from deceased donors located far from the transplant hospital	10
Issue Information	10
Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury	10
Food environment as a determinant of post-transplant diabetes and regional variation in the United States	10
Building a better mouse trap in liver retransplantation risk prediction: Is reSOFT the end or the beginning?	10
“Age ain’t nothing but a number”: Advanced perfusion is the key to increasing the usability of older DCD donor livers	10
Erratum: Living donor liver transplantation with a left trisection plus caudate lobe graft	10
Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients	9
HepB-CpG vaccination: An alternate strategy to lifelong antiviral therapy in patients transplanted for chronic hepatitis B	9
RAPID progress: Living donor liver transplantation for unresectable colorectal liver metastases	9
Policy Corner: Polycystic liver disease MELD exception update	9
Geographic and structural variability in liver transplant outreach programs: A national survey of academic centers	9
Letter to the Editor: Few-shot learning—A methodological bridge from pilot experiments to large-scale studies in refractory ascites research	9
Letter to the Editor: Estimating the cost of liver transplantation	9
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study	9
Reply: Refining early allograft failure risk prediction after LDLT—The importance of including L-GrAFT and EASE scores as comparative benchmarks	9
Reply: Is the SRTR metric “Survival on the Waitlist” still useful in the age of machine perfusion and short liver transplant wait times?	9
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	9
Letter to the Editor: Impact of long-term continuous terlipressin infusion on the liver transplant waitlist in an Australian cohort	8
Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients	8
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?	8
Informatics-driven solutions for optimal care delivery in liver transplantation	8
Management of portal vein thrombosis in candidates for liver transplant	8
Lack of differences in outcomes between 3 immunosuppression protocols in the first year after pediatric liver transplantation: A multicenter study	8
Letter to the Editor: Robust clinician relationships must be the bedrock for future innovations in integrated alcohol-associated liver disease care	8
Issue Information	8
Incidence and outcomes of liver retransplantation using living donor allografts in the US	8
No transplant candidate left behind	8
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?	8
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)	8
Reply: We still need to deal with antibody-mediated rejection in living donor liver transplantation	8
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type	8
Baseline oral microbiome associated with post-living donor liver transplant early complications within 6 months	8
Does hepatectomy technique matter?	7
Optimizing the mouse orthotopic liver transplantation model: Learning curve, technical enhancements, and keys to success	7
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	7
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	7
Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT	7
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers	7
Reduction of hepatectomy times in Dutch organ procurement teams	7
Reply: Estimating the cost of liver transplantation	7
Barriers to liver transplant referral in safety net settings: A national provider survey	7
Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021	7

Liver transplantation for acute-on-chronic liver failure due to carnitine palmitoyl transferase (CPT) 1A deficiency	7
Policy Corner: Cholangitis exception update	7
Financial burden of cirrhosis is significantly reduced after liver transplantation	7
Radiating an advantage: Comparative outcomes in transarterial locoregional therapies favor radioembolization bridging for transplant candidates with hepatocellular carcinoma	7
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement	7
The impact of alcohol-associated liver disease on famous athletes who received liver transplants	7
Strategies and outcomes of multiple bile duct reconstructions in living donor liver transplantation	7
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis	7
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study	7
Fellows’ Corner	7
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	7
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity	7
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost	7
Second thoughts about second opinions for liver transplantation	7
Preservation of coagulation function by normothermic machine perfusion in liver transplant as evidenced by thromboelastography parameters	7
Geospatial analysis of liver donation after death by drug intoxication	7
Issue Information ‐ Instructions to Authors	7
Erratum	7
Portopulmonary hypertension: May we agree to disagree?	7
Letter to the Editor: Plasma exchange for alcohol-associated liver disease as a bridge to liver transplantation—A call to expand its adaptation in Japan	7
Untangling the web of waitlist dropout in HCC	7
Rethinking the use of immunotherapy post-liver transplantation: Standardized protocols with low risk of rejection	6
Retraction: Clinical utility of an automated pupillometer for assessing and monitoring recipients of liver transplantation	6
Harmonizing therapeutic hierarchy and transplant benefit in HCC management	6
Organ monitoring and identification of ischemic liver injury during ex situ porcine liver machine perfusion—A randomized controlled study	6
Every last detail—Managing hepatic artery thrombosis and stenosis in a time of organ scarcity	6
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	6
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	6
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	6
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	6
Liver transplantation in well-selected patients with unresectable colorectal liver metastases	6
A simple intraoperative score incorporating thromboelastometric parameters predicts early reoperation for bleeding after liver transplantation	6
Reply: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	6
When the MELD is low, the bar is high—Gender-related disparities in early liver transplantation	6
Creation of a new VA liver transplantation center increased access and retained care within the Veterans Health Administration	6
“Winning the peace” against obesity in recipients of liver transplant	6
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	6
Potential strategies in porcine liver xenotransplantation: A bridge to allotransplantation and beyond	6
Retraction: Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: Prediction of occurrence of leukopenia	6
Multi-modal machine learning highlights recipient genetic and clinical factors as primary drivers of post-transplant MASLD: A two-center study	6
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	6
Quantitative methods for optimizing patient outcomes in liver transplantation	6
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	6
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	6
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	6
Maximizing outcomes by donor-recipient age matching in liver transplantation	6
Letter to the Editor: Reconsidering fibrinolytic assessment and hemostatic management in liver transplantation	6
Liver transplantation in tight junction protein‐2 deficiency associated liver disease	5
Fellows’ Corner	5
Reply: Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States	5
Salvaging the fatty liver for transplant: is short duration NMP enough?	5
Letter to the Editor: Viability assessment and transplantation of fatty liver grafts using end-ischemic normothermic machine perfusion	5
Outcomes of pediatric candidates for liver retransplantation in the modern era: Strategies are needed to avoid waitlist mortality in the United States	5
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	5
A Modified liver donor risk index for pediatric liver transplant recipients	5
Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology	5
Letter to the Editor: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	5
Is stenting really necessary during primary angioplasty for portal vein stenosis after pediatric liver transplantation?	5
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	5
Prediction of portal venous pressure in living donor liver transplantation: A retrospective study	5
Steatotic liver disease after pediatric liver transplantation	5
	5
Multicenter assessment of hypertension management among liver transplantation recipients	5
Incidence and risk factors for skin cancer in liver transplant recipients: A systematic review	5
Preemptive liver transplantation is essential for patients with severe BSEP deficiency	5
Long‐term follow‐up of living liver donors	5
Utilization of fibrotic HCV-viremic grafts in liver transplantation: An emerging opportunity or a step too far?	5
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis	5
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation—a survey of the International Liver Transplantation Society (ILTS)	5
Outcome of split‐liver transplantation from pediatric donors weighing 25 kg or less	5
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study	5
Reply: Graft inflow modulation by splenic artery ligation in live donor liver transplant recipients in different time frames—A parallax!	5
Jehovah’s Witnesses: Challenges in liver disease management and in liver transplantation	5
Liver transplantation indications and strategies in polycystic liver disease: A european survey	5
Postliver transplant acute cardiomyopathy: Role of prospective cardiac evaluation in immediate posttransplant period	5
Minimally invasive living donor liver transplantation: the future is here	5
The incidence of severe complications in liver donation from living donors: Real-world data in the era of minimally invasive surgery	5
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	5
A novel method using the level of mobility to predict mortality in patients admitted for decompensated cirrhosis: A prospective study	5
Letter to the Editor: Induction therapy in pediatric liver transplants affects outcomes	5
Efficiency of machine perfusion in pediatric liver transplantation	5
A scoping review of nonmedical barriers to living donor liver transplant	5
Issue Information	5
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	5
Living donor liver transplantation in infants 6 kg or less: Impact of graft type and size on postoperative outcomes	5
“Long‐term” is getting longer for children receiving liver transplantation grafts	4
Primary sclerosing cholangitis and the risks of posttransplant lymphoproliferative disorder	4
Multicenter study of racial and ethnic inequities in liver transplantation evaluation: Understanding mechanisms and identifying solutions	4
Closing time	4
Predictive value of controlled attenuation parameter in living liver donors for graft outcomes in corresponding recipients	4
Development of a model to predict the risk of early graft failure after adult-to-adult living donor liver transplantation: An ELTR study	4
CAQ Corner: Evolution of liver allocation policy	4
Expanding the indication of living donor liver transplantation to recipients with PVT: Clinical advances and ongoing challenges	4
Patients are pragmatic and physicians are perfectionists? Comparing success after liver transplantation among patients and physicians	4
Universal intraoperative systemic heparin administration during liver transplantation: A case series	4